Strides Arcolab slumps after final settlement with Mylan
Source: IRIS | 25 Sep, 2014, 12.29PM
|
|
|
|
|
| Rating: NAN / 5 stars. |
 Comments | Post Comment |
|
 Strides Arcolab, a pharmaceutical company manufacturing IP-led niche products, witnessed a fall in share prices on Thursday. The company has agreed to receive an amount of USD 150 million from Mylan, USA that is USD 100 million less from the contingent holdback of upto USD 250 million over the US FDA alert.
 Shares of the company are trading at Rs 670, down Rs 33.55, or 4.77% at the Bombay Stock Exchange (BSE) on Thursday at 12:15 p.m. The scrip has touched an intra-day high of Rs 709 and low of Rs 628.70. The total volume of shares traded at the BSE is 160,253.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
